Key Details
Annual ROE
329.32%Annual Debt To Equity
-12.24Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 26, 2021Recent annual earnings:
May 13, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 25, 2022Analyst ratings
Recent major analysts updates
26 Jan '22 Aegis Capital
Buy26 June '15 Aegis Capital
BuyScreeners with BVXV included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
BiondVax Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of BiondVax Pharmaceuticals?
- What is the ticker symbol for BiondVax Pharmaceuticals?
- Does BiondVax Pharmaceuticals pay dividends?
- What sector is BiondVax Pharmaceuticals in?
- What industry is BiondVax Pharmaceuticals in?
- What country is BiondVax Pharmaceuticals based in?
- When did BiondVax Pharmaceuticals go public?
- Is BiondVax Pharmaceuticals in the S&P 500?
- Is BiondVax Pharmaceuticals in the NASDAQ 100?
- Is BiondVax Pharmaceuticals in the Dow Jones?
- When was BiondVax Pharmaceuticals's last earnings report?
- When does BiondVax Pharmaceuticals report earnings?
What is the primary business of BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
What is the ticker symbol for BiondVax Pharmaceuticals?
The ticker symbol for BiondVax Pharmaceuticals is NASDAQ:BVXV
Does BiondVax Pharmaceuticals pay dividends?
No, BiondVax Pharmaceuticals does not pay dividends
What sector is BiondVax Pharmaceuticals in?
BiondVax Pharmaceuticals is in the Healthcare sector
What industry is BiondVax Pharmaceuticals in?
BiondVax Pharmaceuticals is in the Biotechnology industry
What country is BiondVax Pharmaceuticals based in?
BiondVax Pharmaceuticals is headquartered in Israel
When did BiondVax Pharmaceuticals go public?
BiondVax Pharmaceuticals's initial public offering (IPO) was on 12 May 2015
Is BiondVax Pharmaceuticals in the S&P 500?
No, BiondVax Pharmaceuticals is not included in the S&P 500 index
Is BiondVax Pharmaceuticals in the NASDAQ 100?
No, BiondVax Pharmaceuticals is not included in the NASDAQ 100 index
Is BiondVax Pharmaceuticals in the Dow Jones?
No, BiondVax Pharmaceuticals is not included in the Dow Jones index
When was BiondVax Pharmaceuticals's last earnings report?
BiondVax Pharmaceuticals's most recent earnings report was on 26 August 2021
When does BiondVax Pharmaceuticals report earnings?
The date for BiondVax Pharmaceuticals's next earnings report has not been announced yet